{"id":527,"date":"2015-11-22T03:58:23","date_gmt":"2015-11-22T00:58:23","guid":{"rendered":"http:\/\/www.internalmed-journal.in.ua\/?p=527"},"modified":"2016-06-23T13:27:16","modified_gmt":"2016-06-23T10:27:16","slug":"%d1%81%d0%be%d0%b2%d1%80%d0%b5%d0%bc%d0%b5%d0%bd%d0%bd%d1%8b%d0%b5-%d0%b2%d0%be%d0%b7%d0%bc%d0%be%d0%b6%d0%bd%d0%be%d1%81%d1%82%d0%b8-%d0%b4%d0%b8%d0%b0%d0%b3%d0%bd%d0%be%d1%81%d1%82%d0%b8%d0%ba%d0%b8","status":"publish","type":"post","link":"http:\/\/www.internalmed-journal.in.ua\/en\/archives\/527","title":{"rendered":"Modern possibilities of diagnosis and quantification of liver fibrosis."},"content":{"rendered":"

<\/p>\n

Modern possibilities of diagnosis and quantification of liver fibrosis. <\/strong><\/p>\n

PHD A. Zhuravlyova, PHD O. Ogneva. Kharkiv National Medical University.<\/strong><\/em><\/p>\n

This article is devoted to modern possibilities of early diagnosis of liver fibrosis. Liver fibrosis appears in response to a prolonged chronic liver disease of any origin and further may cause liver cirrhosis and hepatocellular carcinoma. Recently it became known that fibrosis is a dynamic process with a potential opportunity to reverse. Therefore, the definition of its early stages is now very important and can greatly influence the further course of the disease.<\/p>\n

Key Words:<\/strong> liver fibrosis, liver needle biopsy, serum fibrosis markers.<\/p>\n

Zhuravlyova AK, Ogneva OV. [Modern possibilities of diagnosis and quantification of liver fibrosis]. Shidnoevr. z. vnutr. simejnoi med. 2015;2:55-60. Russian.<\/h5>\n
http:\/\/dx.doi.org\/10.15407\/internalmed2015.02.055<\/a><\/h5>\n

Download.PDF<\/a><\/p>\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
1. Manning DS, Afdhal NH [Diagnosis and Quantification of fibrosis] Gastroenterology. 2008; 134 (6): 1670-1681. English
\nhttp:\/\/dx.doi.org\/10.1053\/j.gastro.2008.03.001<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
2. Regev A, Berho M, Jeffers LJ. [Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection] Am J Gastroenterol. 2002; 97: 2614\u20142618. English
\nhttp:\/\/dx.doi.org\/10.1111\/j.1572-0241.2002.06038.x<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
3. Lindor KD, Bru C, Jorgensen RA. [The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy] Hepatology. 1996; 23: 1079\u2014 1083. English
\nhttp:\/\/dx.doi.org\/10.1002\/hep.510230522<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
4. Thampanitchawong P, Piratvisuth T. [Liver biopsy: complications and risk factors] World J Gastroenterol. 1999; 5: 301\u2014304. English
\nhttp:\/\/dx.doi.org\/10.3748\/wjg.v5.i4.301<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
5. Terjung B, Lemnitzer I, Dumoulin FL. [Bleeding complications after percutaneous liver biopsy (An analysis of risk factors)] Digestion. 2003; 67: 138\u2014145. English
\nhttp:\/\/dx.doi.org\/10.1159\/000071293<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
6. Poniachik J, Bernstein DE, Reddy KR. [The role of laparoscopy in the diagnosis of cirrhosis]. Gastrointest Endosc. 1996; 43: 568\u2014571. English
\nhttp:\/\/dx.doi.org\/10.1016\/S0016-5107(96)70192-X<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
7. Bedossa P, Dargere D, Paradis V. [Sampling variability of liver fibrosis in chronic hepatitis C]. Hepatology. 2003; 38: 1449\u20141457. English
\nhttp:\/\/dx.doi.org\/10.1053\/jhep.2003.09022<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
8. OBrien MJ, Keating NM, Elderiny S. [An assessment of digital image analysis to measure fibrosis in liver biopsy specimens of patients with chronic hepatitis C]. Am J Clin Pathol. 2000; 114: 712\u2014718. English<\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
9. Parkes J, Guha IN, Roderick P. [Performance of serum marker panels for liver fibrosis in chronic hepatitis C]. J Hepatol. 2006; 44: 462\u2014474. English
\nhttp:\/\/dx.doi.org\/10.1016\/j.jhep.2005.10.019<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
10. Imbert-Bismut F, Ratziu V, Pieroni L. [Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study]. Lancet. 2001; 357: 1069\u20141075. English
\nhttp:\/\/dx.doi.org\/10.1016\/S0140-6736(00)04258-6<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
11. Thabut D, Simon M, Myers RP. [Noninvasive prediction of fibrosis in patients with chronic hepatitis] Hepatology. 2003; 37: 1220\u20141221. English
\nhttp:\/\/dx.doi.org\/10.1053\/jhep.2003.50109<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
12. Wai CT, Greenson JK, Fontana RJ. [A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C]. Hepatology. 2003; 38: 518\u2014526. English
\nhttp:\/\/dx.doi.org\/10.1053\/jhep.2003.50346<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
13. Anderson FH, Zeng L, Rock NR. [An assessment of the clinical utility of serum ALT and AST in chronic hepatitis C]. Hepatol Res. 2000; 18: 63\u201471. English
\nhttp:\/\/dx.doi.org\/10.1016\/S1386-6346(99)00085-6<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
14. Park GJ, Lin BP, Ngu MC. [Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?]. J GastroenterolHepatol. 2000; 15: 386\u2014390. English
\nhttp:\/\/dx.doi.org\/10.1046\/j.1440-1746.2000.02172.x<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
15. Kawasaki T, Takeshita A, Souda K. [Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis]. Am J Gastroenterol. 1999; 94: 1918\u20141922. English
\nhttp:\/\/dx.doi.org\/10.1111\/j.1572-0241.1999.01231.x<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
16. Shaheen AA, Myers RP. [Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review]. Hepatology. 2007; 46: 912\u2014921. English
\nhttp:\/\/dx.doi.org\/10.1002\/hep.21835<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
17. Teare JP, Sherman D, Greenfield SM. [Comparison of serum procollagen III peptide concentrations and PGA index for assessment of hepatic fibrosis]. Lancet. 1993; 342: 895\u2014898. English
\nhttp:\/\/dx.doi.org\/10.1016\/0140-6736(93)91946-J<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
18. Rossi E, Adams L, Prins A. [Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients]. Clin Chem. 2003; 49: 450\u2014454. English
\nhttp:\/\/dx.doi.org\/10.1373\/49.3.450<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
19. Poynard T, Morra R, Halfon P. [Meta-analyses of Fibrotest diagnostic value in chronic liver disease]. BMC Gastroenterol. 2007; 7: 40 English
\nhttp:\/\/dx.doi.org\/10.1186\/1471-230X-7-40<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
20. Pares A, Deulofeu R, Gimenez A. [Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis]. Hepatology. 1996; 24: 1399\u20141403. English
\nhttp:\/\/dx.doi.org\/10.1002\/hep.510240615<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
21. Giannini E, Caglieris S, Ceppa P. [Serum pro-collagen III peptide levels are related to lobular necrosis in untreated patients with chronic hepatitis C]. Eur J Gastroenterol Hepatol. \u2014 2001; 13: 137\u2014141. English
\nhttp:\/\/dx.doi.org\/10.1097\/00042737-200102000-00008<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
22. Khan S, Subedi D, Chowdhury MM. [Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis]. Postgrad Med J. 2006; 82: 353\u2014354. English
\nhttp:\/\/dx.doi.org\/10.1136\/pgmj.2005.041533<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
23. Boeker KH, Haberkorn CI, Michels D. [Diagnostic potential of circulating TIMP-1 and MMP-2 as markers of liver fibrosis in patients with chronic hepatitis C]. ClinChimActa. 2002; 316: 71\u201481. English
\nhttp:\/\/dx.doi.org\/10.1016\/S0009-8981(01)00730-6<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
24. Larrousse M, Laguno M, Segarra M. [Noninvasive diagnosis of hepatic fibrosis in HIV\/HCV-coinfected patients]. J Acquir Immune DeficSyndr. 2007; 46: 304\u2014311. English
\nhttp:\/\/dx.doi.org\/10.1097\/QAI.0b013e3181520502<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
25. McClain CJ, Cohen DA. [Increased tumor necrosis factor production by monocytes in alcoholic hepatitis]. Hepatology. 1989; 9: 349\u2014351. English
\nhttp:\/\/dx.doi.org\/10.1002\/hep.1840090302<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
26. Ikura Y, Morimoto H, Ogami M. [Expression of platelet-derived growth factor and its receptor in livers of patients with chronic liver disease]. J Gastroenterol. 1997; 32: 496\u2014501. English
\nhttp:\/\/dx.doi.org\/10.1007\/BF02934089<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
27. Rosenberg WM, Michael V, Robert T. [Serum markers detect the presence of liver fibrosis: A cohort study]. Gastroenterology. 2012; 127 (6): 1704-1713. English
\nhttp:\/\/dx.doi.org\/10.1053\/j.gastro.2004.08.052<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
28. Kelleher TB, Mehta SH, Bhaskar R. [Prediction of hepatic fibrosis in HIV\/HCV co-infected patients using serum fibrosis markers: the SHASTA index]. J Hepatol. 2005; 43: 78\u201484. English
\nhttp:\/\/dx.doi.org\/10.1016\/j.jhep.2005.02.025<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
29. Honda H, Onitsuka H, Masuda K. [Chronic liver disease: value of volumetry of liver and spleen with computed tomography]. Radiat Med. 1990; 8: 222\u2014226. English<\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
30. Kettaneh A, Marcellin P, Douvin C. [Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients]. J Hepatol. 2007; 46: 628\u2014634. English
\nhttp:\/\/dx.doi.org\/10.1016\/j.jhep.2006.11.010<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
31. Ziol M, Handra-Luca A, Kettaneh A. [Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C]. Hepatology. 2005; 41: 48\u201454. English
\nhttp:\/\/dx.doi.org\/10.1002\/hep.20506<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
32. Talwalkar JA, Kurtz DM, Schoenleber SJ. [Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis]. ClinGastroenterolHepatol. 2007; 5: 1214\u20141220. English
\nhttp:\/\/dx.doi.org\/10.1016\/j.cgh.2007.07.020<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
33. Shaheen AA, Wan AF, Myers RP. [FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy]. Am J Gastroenterol. 2007; 102: 2589\u20142600. English
\nhttp:\/\/dx.doi.org\/10.1111\/j.1572-0241.2007.01466.x<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
34. Huwart L, Peeters F, Sinkus R. [Liver fibrosis: noninvasive assessment with MR elastography]. NMR Biomed. 2006; 19: 173\u2014179. English
\nhttp:\/\/dx.doi.org\/10.1002\/nbm.1030<\/a><\/td>\n<\/tr>\n
<\/td>\n<\/tr>\n
35. Yin M, Talwalkar JA, Glaser KJ. [Assessment of hepatic fibrosis with magnetic resonance elastography]. ClinGastroenterolHepatol. 2007; 5: 1207\u20141213. English
\nhttp:\/\/dx.doi.org\/10.1016\/j.cgh.2007.06.012<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[8,25],"tags":[],"translation":{"provider":"WPGlobus","version":"2.12.2","language":"en","enabled_languages":["uk","en","ru"],"languages":{"uk":{"title":true,"content":true,"excerpt":false},"en":{"title":true,"content":true,"excerpt":false},"ru":{"title":true,"content":true,"excerpt":false}}},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","_links":{"self":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/527"}],"collection":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/comments?post=527"}],"version-history":[{"count":4,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/527\/revisions"}],"predecessor-version":[{"id":811,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/posts\/527\/revisions\/811"}],"wp:attachment":[{"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/media?parent=527"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/categories?post=527"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/www.internalmed-journal.in.ua\/en\/wp-json\/wp\/v2\/tags?post=527"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}